Explore 3 Stock Ideas & Industry Insights Download Free Report

Green Thumb Industries Inc

Healthcare US GTBIF

7.95USD
-0.28(3.40%)

Last update at 2026-06-12T20:00:00Z

Day Range

7.918.26
LowHigh

52 Week Range

4.8010.43
LowHigh

Fundamentals

  • Previous Close 8.23
  • Market Cap1710.90M
  • Volume118641
  • P/E Ratio15.00
  • Dividend Yield-%
  • EBITDA283.15M
  • Revenue TTM1175.29M
  • Revenue Per Share TTM5.03
  • Gross Profit TTM 574.89M
  • Diluted EPS TTM0.48

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 263.36M 200.14M 156.05M 108.43M 204.97M
Minority interest -1.90100M -0.76800M -1.15200M -1.67700M 4.93M
Net income 114.15M 73.08M 36.27M 11.98M 75.44M
Selling general administrative 437.19M 376.68M 341.86M 294.40M 277.09M
Selling and marketing expenses - - - - -
Gross profit 574.89M 601.11M 526.50M 503.96M 491.93M
Reconciled depreciation 197.01M 167.59M 149.02M 140.65M 102.58M
Ebit - - - 210.99M 226.95M
Ebitda - - - 129.63M 329.53M
Depreciation and amortization - - - - -
Non operating income net other - - - - 12.11M
Operating income 137.70M 224.43M 184.63M 209.57M 214.84M
Other operating expenses - - - - -
Interest expense 20.02M 24.27M 19.07M 21.20M 21.98M
Tax provision 147.30M 126.29M 118.63M 94.78M 124.61M
Interest income 11.38M 9.07M 6.70M 4.07M 1.43M
Net interest income -8.64100M -15.19200M -12.37600M -17.13100M -20.54400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 94.78M 124.61M
Total revenue 1175.30M 1137.14M 1054.55M 1017.38M 893.56M
Total operating expenses 1037.60M 912.72M 869.92M 807.81M 277.09M
Cost of revenue 600.40M 536.03M 528.06M 513.41M 401.63M
Total other income expense net 134.30M -9.09400M -16.20700M -84.00400M 10.68M
Discontinued operations - - - - -
Net income from continuing ops 116.05M 73.85M 37.42M 13.65M 80.36M
Net income applicable to common shares - - - 11.98M 75.44M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2790.06M 2537.01M 2490.06M 2433.53M 2385.85M
Intangible assets 436.68M 488.29M 538.68M 589.52M 675.49M
Earning assets - - - - -
Other current assets 18.40M 14.68M 5.38M 197.23M 246.66M
Total liab 879.41M 747.93M 786.80M 768.10M 766.37M
Total stockholder equity 1905.43M 1789.08M 1703.26M 1664.92M 1621.12M
Deferred long term liab - - - - 81.85M
Other current liab - - - 369.20M 91.24M
Common stock - - - 1663.56M 1619.48M
Capital stock 1780.59M 1758.50M 1703.85M 1663.56M 1633.67M
Retained earnings 165.42M 51.27M -21.81800M -58.08500M -70.06300M
Other liab - - - 97.61M 140.30M
Good will 592.15M 589.69M 589.69M 589.69M 632.85M
Other assets - - - 3.06M 127.88M
Cash 274.30M 171.69M 161.63M 177.68M 230.42M
Cash and equivalents - - - - -
Total current liabilities 177.31M 164.97M 126.05M 146.57M 204.38M
Current deferred revenue - - - - -
Net debt - 83.27M 146.89M 96.95M 9.51M
Short term debt - - - 275.67M 0.78M
Short long term debt 18.50M 12.06M 3.00M 1.04M 0.78M
Short long term debt total - - - - -
Other stockholder equity - - - 1641.68M 1527.35M
Property plant equipment - - - 557.87M 409.07M
Total current assets 577.17M 403.90M 342.76M 351.35M 364.23M
Long term investments 205.88M 83.88M 89.30M 74.17M 94.90M
Net tangible assets - - - 485.71M 312.78M
Short term investments - - - - -
Net receivables 51.27M 52.83M 42.98M 38.45M 22.10M
Long term debt 226.40M 242.90M 305.53M 274.63M 239.15M
Inventory 158.29M 147.16M 112.97M 115.67M 95.47M
Accounts payable 24.57M 24.77M 24.50M 123.23M 112.36M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 0.52M -1.63800M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.10M 2.17M 2.56M 270.93M 209.31M
Deferred long term asset charges - - - - -
Non current assets total 2212.89M 2133.11M 2147.30M 2082.18M 2021.62M
Capital lease obligations 273.45M 275.74M 261.76M 249.28M 191.76M
Long term debt total - - - - 239.15M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -75.49200M -9.79800M -8.30200M -5.80400M -60.63300M
Change to liabilities - - - 0.69M -13.97500M
Total cashflows from investing activities - - - -219.94600M -280.73000M
Net borrowings -10.70100M -56.63800M 24.42M 19.15M 138.19M
Total cash from financing activities -50.94300M -95.59400M -13.10800M 8.64M 295.34M
Change to operating activities - - - -39.53800M -24.04400M
Net income 114.15M 73.08M 36.27M 11.98M 75.44M
Change in cash 113.59M 10.05M -16.04800M -52.73800M 146.66M
Begin period cash flow 171.69M 161.63M 177.68M 230.42M 83.76M
End period cash flow 285.28M 171.69M 161.63M 177.68M 230.42M
Total cash from operating activities 294.93M 195.18M 224.97M 158.56M 132.05M
Issuance of capital stock - - 0.00000M 0.00000M 155.50M
Depreciation 197.01M 167.59M 149.02M 105.84M 75.69M
Other cashflows from investing activities - - - -34.64200M -32.24700M
Dividends paid - - - - 11.03M
Change to inventory -12.89100M -35.02300M 1.12M -19.79100M -16.43900M
Change to account receivables 1.09M -9.85600M -12.00000M -9.26400M -0.64600M
Sale purchase of stock -38.87300M -43.07800M -39.85600M 3.82M 169.76M
Other cashflows from financing activities - - - -14.32900M -12.60700M
Change to netincome - - - 77.31M 22.92M
Capital expenditures 81.07M 80.19M 220.03M 179.50M 187.85M
Change receivables - - - -9.26400M -0.64600M
Cash flows other operating - - - -27.99100M 29.82M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - -52.73800M 146.66M
Change in working capital -75.93200M -83.46900M -35.84400M -70.26600M -65.26900M
Stock based compensation 44.93M 33.31M 28.19M 27.14M 19.60M
Other non cash items -5.73500M -12.54800M 9.53M -21.41800M 6.10M
Free cash flow 213.86M 115.00M 4.93M -20.93600M -55.80200M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GTBIF
Green Thumb Industries Inc
-0.28 3.40% 7.95 15.00 35.34 1.46 0.88 1.60 3.92
ZTS
Zoetis Inc
-1.83 2.25% 79.57 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
-0.76 2.39% 31.02 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-5.55 3.44% 155.60 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG
0.21 0.48% 43.24 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

Profile

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

Green Thumb Industries Inc

325 West Huron Street, Chicago, IL, United States, 60654

Key Executives

Name Title Year Born
Mr. Benjamin Kovler Founder, Chairman & CEO 1979
Mr. Anthony Georgiadis CFO & Director 1978
Mr. Mathew Faulkner Chief Accounting Officer 1973
Mr. Swadheen Sehgal Chief Information Officer NA
Mr. Andrew Laurence Grossman EVP of Capital Markets & Investor Relations 1974
Ms. Linda Marsicano VP of Communications 1968
Mr. Daniel Shaker Sr. VP of National Sales 1971
Ms. Kate Denton Sr. VP of Marketing NA
Mr. Bret Kravitz Chief Corp. Counsel 1980
Ms. Dina Rollman Sr. VP of Gov. & Regulatory Affairs 1973

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.